i-SENS Inc (099190) - Total Liabilities
Based on the latest financial reports, i-SENS Inc (099190) has total liabilities worth ₩238.13 Billion KRW (≈ $161.37 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore i-SENS Inc (099190) cash flow conversion to assess how effectively this company generates cash.
i-SENS Inc - Total Liabilities Trend (2012–2024)
This chart illustrates how i-SENS Inc's total liabilities have evolved over time, based on quarterly financial data. Check i-SENS Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
i-SENS Inc Competitors by Total Liabilities
The table below lists competitors of i-SENS Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SNS
KLSE:0259
|
Malaysia | RM383.01 Million |
|
Quang Viet Enterprise Co Ltd
TW:4438
|
Taiwan | NT$12.00 Billion |
|
United Pharm
KO:033270
|
Korea | ₩64.86 Billion |
|
Catella AB (publ)
ST:CAT-B
|
Sweden | Skr2.18 Billion |
|
Atomera Inc
NASDAQ:ATOM
|
USA | $2.71 Million |
|
Aurora Cannabis Inc
NASDAQ:ACB
|
USA | $207.47 Million |
|
Mechema Chemicals Int
TWO:4721
|
Taiwan | NT$843.04 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down i-SENS Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see i-SENS Inc market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how i-SENS Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for i-SENS Inc (2012–2024)
The table below shows the annual total liabilities of i-SENS Inc from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩247.89 Billion ≈ $167.99 Million |
+26.91% |
| 2023-12-31 | ₩195.32 Billion ≈ $132.37 Million |
+19.27% |
| 2022-12-31 | ₩163.76 Billion ≈ $110.98 Million |
+1.81% |
| 2021-12-31 | ₩160.85 Billion ≈ $109.00 Million |
+83.75% |
| 2020-12-31 | ₩87.54 Billion ≈ $59.32 Million |
+22.46% |
| 2019-12-31 | ₩71.48 Billion ≈ $48.44 Million |
+0.50% |
| 2018-12-31 | ₩71.12 Billion ≈ $48.20 Million |
-0.22% |
| 2017-12-31 | ₩71.28 Billion ≈ $48.31 Million |
+9.00% |
| 2016-12-31 | ₩65.39 Billion ≈ $44.32 Million |
+36.87% |
| 2015-12-31 | ₩47.78 Billion ≈ $32.38 Million |
+6.88% |
| 2014-12-31 | ₩44.70 Billion ≈ $30.29 Million |
+20.50% |
| 2013-12-31 | ₩37.10 Billion ≈ $25.14 Million |
+57.12% |
| 2012-12-31 | ₩23.61 Billion ≈ $16.00 Million |
-- |
About i-SENS Inc
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more